Approximately 200,000,000 people have schistosomiasis (schistosome infection). Among the schistosomes, Schistosoma haematobium is responsible for the most infections-110 million people globally, mostly in sub-Saharan Africa. This pathogen causes an astonishing breadth of sequelae-hematuria, anemia, dysuria, stunting, uremia, bladder cancer, urosepsis, and HIV coinfection. Refined estimates of the quality of life impact of schistosomiasis suggest it rivals malaria. Despite S. haematobium's importance, relevant research has lagged. Here, we review advances that will deepen knowledge of S. haematobium. Three sets of breakthroughs will accelerate discoveries in the pathogenesis of urogenital schistosomiasis (UGS): (1) comparative genomics; (2) the development of functional genomic tools; and (3) use of animal models to explore S. haematobium-host interactions. Comparative genomics for S. haematobium is feasible, given the sequencing of multiple schistosome genomes. Features of the S. haematobium genome that are conserved among platyhelminth species, and others that are unique to S. haematobium may provide novel diagnostic and drug targets for UGS. Though there are technical hurdles, the integrated use of these approaches can elucidate host-pathogen interactions during this infection, and inform development of techniques for investigating schistosomes in their human and snail hosts and therapeutics and vaccines for the control of UGS. at GWU on October 23, 2014 http://jid.oxfordjournals.org/ Downloaded from
A c c e p t e d M a n u s c r i p t 4
Methodology/Principal Findings
Recent, major advances in the field will significantly facilitate discoveries in the pathophysiology of UGS: (1) comparative genomics; (2) functional genomics; and (3) tractable animal models to explore the interactions of S. haematobium with host systems (Figure 1 ). Access to the S. haematobium genome and transcriptome of male and female adult worms and eggs will allow comparative -omic studies (5) . Features of the S. haematobium genome that are conserved among members of Platyhelminthes and unique to S. haematobium are likely to provide new diagnostic and therapeutic targets for UGS. Moreover, RNA interference (RNAi) pathways in S. haematobium may be exploited to suppress key biomolecules for the viability, development and infectivity of this pathogen (6) .
Genomes -a major step forward
Following the sequencing of the eukaryotic model organisms, including Caenorhabditis elegans, (7) , improved, automated Sanger sequencing methods facilitated the characterization of the genomes of the first metazoan parasites, including S. mansoni and S. japonicum. These genomes provided the first, global previews of the genetics of schistosomes. In 2010, the completion of the draft genome of the giant panda using solely Illumina/Solexa-based (massively parallel) sequencing (8) led to a revolution in the sequencing of an expanding catalog of metazoans, and the S. haematobium genome ensued rapidly (5) . In this latter project, total genomic DNA from a single pair of worms was subjected to whole-genome amplification followed by sequencing; the genome was assembled and annotated employing deep transcriptomic data from the egg and adult developmental stages (5) . The availability of the draft genomes of all three main species of schistosomes of humans has paved the way for extensive at GWU on October 23, 2014 http://jid.oxfordjournals.org/ Downloaded from A c c e p t e d M a n u s c r i p t 5 comparative (9) and functional genomics and for deep research of parasite-host interactions and pathogenesis (10) .
Toward enhanced annotation and curated databases
The functional annotation of schistosome genes has relied on homology-based bioinformatic analyses that assign gene annotation(s) from other species. This process infers that homologous proteins have conserved functions, although many schistosome proteins do not have orthologs in other taxa for which genomic, transcriptomic and/or proteomic information are available. Thus, numerous schistosome proteins remain refractory to annotation, e.g., of the 13,073 genes predicted for S. haematobium, only ~ 50% are homologous to curated sequences in the SwissProt:UniProt Knowledgebase(5), or predicted to encode conserved amino acid sequence domains (InterPro) (5) . Furthermore, only ~40% of genes are linked to conserved biological pathways in the Kyoto Encyclopedia of Genes and Genomes (KEGG) (5) or processes inferred by gene ontology (GO) (5) . The platyhelminths, including the schistosomes, are lophotrochozoans, distinct developmentally from members of the Ecdysozoa (e.g., D.
melanogaster and C. elegans) and the Deuterostoma (e.g., Homo sapiens and M. musculus) whose genomes have been functionally annotated [e.g., (7) ]. Therefore, the challenging functional annotation of schistosome genes and proteins relate to their evolutionary distinctiveness from other organisms for which genomes have been well characterized. Improvements in cross-taxon annotation can be achieved by integrating genomic and other omics data (11) . In schistosomes, the first step was the curation of the annotated genomes of S. haematobium, S. japonicum and S. mansoni within the public database, SchistoDB (12) . The recent integration of data from these three species now enables informative data mining and definition of genes, GO terms, conserved domains and biological pathways. Together with databases from other key flatworm species, including GeneDB (13) and HelmDB (14) , access is A c c e p t e d M a n u s c r i p t 6 now available to an abundance of genomic, transcriptomic and proteomic data to construct biological pathways and prioritize drug or vaccine candidates (15) . Furthermore, the identification of parasitic flatworm orthologs in the draft genomes and transcriptomes of freeliving species of flatworms that have been established as models for stem cell regeneration could facilitate molecular investigations into the biology of S. haematobium (16). To identify orthologs, SchistoDB and HelmDB contain protein-clustering algorithms to enhance the prediction of orthologs and paralogs. Therefore, whereas functional annotation of S. haematobium genes is limited, it is possible to confidently infer orthologs among the species of schistosomes. Methods used to define orthology/paralogy vary (17) , but they all involve identification of orthologous genes/proteins shared by two or more species, usually based on pairwise sequence alignments (18) . Based on sequence homology (BLASTp, E-value ≤ 10-5), genome-wide comparisons of the inferred proteome of S. haematobium revealed that 1,369, 244 and 10,880 proteins are homologous to those of S. mansoni alone, S. japonicum and both species, respectively. Overall, pairwise comparisons of shared proteins among the schistosomes showed that most annotated biological pathways are shared (5) . Differences are evident among macromolecules associated with cell-cycle regulation, membrane transport and signaling, translation, and lipid/xenobiotic metabolism in S. haematobium and S. mansoni versus S. japonicum, and transcription in S. haematobium and S. japonicum versus S. mansoni.
In addition, a subset of 73 predicted enzymes and other proteins was unique to S. haematobium (5) . By using an OrthoMCL clustering approach (17), the schistosome proteomes share 6,968 orthologous clusters, of which 5,389 clusters were represented by single-copy genes. In addition, this approach identified orthologous gene clusters exclusive to S. haematobium and S. mansoni (1138 clusters; 989 single-copy genes) and S. haematobium and S. japonicum (689 clusters; 654 single-copy genes). These findings indicate that further annotation of each gene set, using similar bioinformatic tools employed to characterize the kinome (19) and G-coupled protein receptors (20) of S. mansoni, will likely reveal differences in physiology among the three 
Functional genomics
Insights into the -omics of S. haematobium may be confirmed and expanded by functional testing of gene candidates, particularly those exhibiting novelty or evolutionary divergence among orthologs from the schistosome species. We anticipate that the transgenesis of S.
haematobium, in addition to other genome manipulation approaches, will accelerate discoveries relevant to UGS by querying gene function over the developmental cycle, including in cercariae, schistosomula, adult worms, eggs, and sporocysts within the intermediate host snail (21) .
Indeed, progress has been made in this area, and rapid advances can be predicted in development of functional genomic tools for forward and/or reverse genetic investigations of S. haematobium (5, 22, 23) . However, it has been more difficult to deploy transgenesis to S. haematobium, in comparison with S. mansoni and S. japonicum, largely because the developmental cycle of S. haematobium is challenging to maintain in laboratory mice.
To overcome these hurdles, Rinaldi and coworkers (21) haematobium. In addition, firefly luciferase mRNA is translated in S. haematobium cells.
Notably, these studies confirmed that RNA interference (RNAi) pathway is active in this schistosome; both a reporter transgene (luciferase) and an endogenous S. haematobium gene encoding the tegumental antigen tetraspanin-2 were post-transcriptionally silenced after specific RNA interfering molecules (siRNA and dsRNA) were introduced into the egg, schistosomular, and adult stages of this blood fluke (21) .
We are now attempting to establish stable transfection employing the integration competent vector, pseudotyped murine leukemia virus retrovirus (24) . Other integration-competent vectors, including the transposon piggyBac, that can integrate into schistosome chromosomes, will be investigated (25) ; this approach also shows promise for germline transgenesis in other parasitic helminths (26) . S. mansoni transgenesis techniques, i.e., piggyBac and retroviruses, are facilitating the development of forward genetics (i.e. insertional mutagenesis analysis), reverse genetics, (i.e. loss-of-function approaches), gain-of-function approaches, and overexpression of reporters (e.g., genes encoding for antibiotic resistance). Thus, we anticipate that this technology will be transferable to S. haematobium. Table 1 presents a brief summary of the approaches and tools that have been modified and deployed for use in functional genomic studies of schistosomes. Although progress is farthest advanced in S. mansoni, physiological impediments are not apparent that should thwart application to S. haematobium to derive stable transgenic lines (27) ( Figure 3 ). Figure 4 (CRISPR)-associated endonucleases (e.g., Cas9), have been successfully applied to C. elegans to generate transgenic organisms and introduce site-specific, heritable mutations (28) .
It is expected that this emerging technology will be transferable to parasitic helminths, thereby expanding the nascent toolkit for functional genomic investigations of schistosomes (29) . (32)), host range, tropism of this species for the pelvic rather than intestinal circulation, and so forth. Some non-human primates are suitable hosts for S. haematobium, including patas and vervet monkeys and baboons (33) (34) (35) (36) (37) (38) (39) (40) (41) . Application of genomics approaches (e.g. genome editing) to primate models themselves would likely be informative (42) .
Technological advances in the study of UGS should have translational value. The accurate detection of infection, the central goal of diagnostics for schistosomiasis, is based on analytes that vary in form and source (i.e., protein vs. nucleic acid, worm vs. egg) across existing candidates vying for adoption. It is likely, however, that novel diagnostics using markers from A c c e p t e d M a n u s c r i p t 10 the S. haematobium genome will be nucleic acid-based, or based on the protein products of characterized genes. These considerations also apply to diagnostic tools designed for detection of cercariae in water and sporocysts in snails (43) .
Considering the translational potential of functional genomics of S. haematobium, it is informative to examine the developmental stages. For instance, candidate vaccines for UGS are likely to be based on findings derived from cercariae, schistosomules, and adult stages, since the goal of such vaccines is to break the cycle of infection (44) . In contrast, candidate drugs for UGS could target all of these life stages, including the egg, to prevent egg-induced pathology.
Lastly, molecular characterization of the sporocyst stage may reveal new strategies for interrupting or disrupting the infection of snails by S. haematobium.
The potential for functional genomics of S. haematobium to improve diagnostics, drugs and vaccines is representative of the intersection between population-based field studies and functional genomics. Fieldwork in UGS, in the form of genetic cataloging of S. haematobium strains, will also be relevant to functional genomics by facilitating improved annotation of parasite gene functions and interactions. Such studies will be critical to validating observations of host-parasite interactions obtained through Hsieh's egg injection mouse models. Whether the effects of infection with S. mansoni on the liver and intestine are analogous to processes occurring in the bladder during UGS is not known. Thus, it is critical to identify and characterize the acute changes initiated in mammalian bladder tissue in UGS and to establish how these processes are linked to morbidity over time. This is a key area of inquiry to improve the diagnosis and therapy of complications of UGS.
The testing of hypotheses using new animal models of UGS
Historically, the primary in vivo models for UGS have been S. haematobium cercariae-infected hamsters and non-human primates (45) . Although these infections support the maturation of the parasite and and oviposition, use of these animals as research models of human disease feature challenges. Hamsters (Mesocricetus auratus) exhibit low rates of pelvic organ infection, the key site of human pathology, and instead develop predominantly hepato-enteric schistosomiasis. Hence, while useful, the model is not amenable for studying disease and oviposition in pelvic organs. Moreover, there are few hamster-specific reagents and tools -primary antibodies, cytokines, transgenic strains, etc. available for mechanistic studies. Nonhuman primates do exhibit urogenital disease; however, use of these mammals requires substantial ethical justification, suffers from a lack of species-specific tools, and is expensive.
Nevertheless, a number of non-human primates are receptive hosts for S. haematobium, i.e., patas (Erythrocebus patas) and vervet (Chlorocebus aethiops) monkeys and Papio spp.
baboons (33) (34) (35) (36) (37) (38) (39) (40) (41) . Use of parasite-and host-specific genomics techniques should be possible with these animal models. infections, attempts to transdermally infect mice with S. haematobium cercariae produce only light infections of the hepato-enteric systems and little or no oviposition in the pelvic organs (46) . An inability to model this key pathogenic phase of infection in mice is particularly unfortunate, given the wide range of species-specific tools that are available for mouse research. Therefore, until recently, approaches for modeling UGS in experimental animals have been largely unsuccessful.
We developed techniques that mimic the key pathological changes induced by S. haematobium oviposition in bladder tissue. We reasoned that direct administration of schistosome eggs into the mouse bladder wall could reproduce pathological elements of human bladder schistosomiasis. By analogy, our understanding of pulmonary fibrosis has been greatly aided by many studies of tail vein injection of S. mansoni eggs that lodge in the pulmonary capillary beds. Thus, administration of S. haematobium eggs directly into bladder tissue has the potential to be at least as relevant for understanding the pathogenesis of disease in the bladder.
Injection of S. haematobium eggs into the lamina propria of the mouse bladder-the tissue layer
where egg granulomata are found in infected human bladders-recapitulated key aspects of the bladder disease of UGS (32) . Specifically, egg injection resulted in hematuria, increased urinary frequency, the development of persistent, fibrotic bladder granulomata, and systemic and regional type 2 immune activation (32) .
A bolus injection of S. haematobium eggs is suitable for the controlled study of synchronized, egg-induced changes in host tissue. Microarray analysis of the whole bladder transcriptome using this model revealed differential transcription of multiple genes relevant to inflammatory fibrosis and urothelial function (47) . This was the first characterization of the early transcriptional events occurring in the bladder after exposure to S. haematobium eggs. These data, derived 
Conclusions/Significance
Comparative genomics will generate new hypotheses regarding mechanisms of pathogenesis that can be tested through genetic manipulation of Schistosoma haematobium in the context of wild type and transgenic mouse models. The integrated use of these new technologies by to assign roles to novel sequences (red arrow 1). Transgenesis would also facilitate forward genetics by insertional mutagenesis that, in turn, can be analyzed by genomic approaches (blue arrow 1). Genetically modified parasites would be tested in tractable rodent models (blue arrow 2) and parasites obtained from these models studied using genomic approaches (green arrow 2) and functional tools (green arrow 1). Hypotheses derived from comparative genomic approaches would tested using functional genomic tools (red arrow 1) and animal models of urogenital schistosomiasis (red arrow 2) shows bladder wall injection with S. haematobium eggs (as described by Hsieh and colleagues (32) ). The egg bolus can be seen as a semi-opaque bleb localized to the bladder wall (blue arrow). 
